You just read:

Novel Gene Therapy Shows Three-Fold Improvement in Recurrence-Free Survival in High-Risk, Early-Stage Bladder Cancer Patients Where Current Gold-Standard Treatment Fails

News provided by

Society of Urologic Oncology

Aug 24, 2017, 07:00 ET